Groundbreaking research unveils potential link between cytomegalovirus and Alzheimer's disease, offering new hope for ...

Discover how dopamine’s unexpected role in breaking down harmful plaques could revolutionize Alzheimer's treatment and ...

MAYBE you’ve promised yourself you’ll hit the gym five days a week and you’ve already skipped several sessions. Or perhaps ...

The pathology of Alzheimer’s disease was identified in 1906. We remain with neither cure nor treatments that reverse symptoms or stop disease progression. Recently approved treatments have ...

Gum disease appears to disrupt brain activity, potentially increasing a person’s risk of cognitive decline.People with ...

I have a special interest in Alzheimer’s disease. For nearly 25 years, I practiced general neurology in Portland, Oregon, and ...

Learn how stem cells from menstrual blood period blood might help treat Alzheimer’s disease A study shows how they can ...

The Phase Ia trial is designed to assess the company’s drug designed to target chemicals thought to be a cause of Alzheimer’s disease.

The era of targeting these proteins at an early stage to minimise risk of Alzheimer’s progressing has started. The prospect ...

INmune Bio's XPro targets neuroinflammation, showing promising biomarker results in Alzheimer's, with a potential to ...

ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company focused on developing precision therapies for neurodegenerative diseases, today announced the initiation of its Phase 1b ...